The countdown for New York's I-STOP legislation has begun. Are you ready?
Effective March 27th, 2016, the Internet System for Tracking Over-Prescribing (I-STOP) Act requires electronic prescribing of all medications, including controlled substances, in the state of New York. There are many requirements for Electronic Prescribing of Controlled Substances (EPCS) and for I-STOP. Prescribers must use e-prescribing software that has been certified and audited, complete an identity proofing process, obtain two-factor authentication for each prescription, in accordance with Drug Enforcement Agency (DEA) regulations, and register substance e-prescribing software with the Bureau of Narcotic Enforcement (BNE).
In this webinar, Lawrence H. Mokhiber, BS, MS, RPh, Executive Secretary, New York State Board of Pharmacy, and William T. Winsley, MS, RPh, Former Executive Director, Ohio State Board of Pharmacy, answer FAQs relating to I-STOP and DEA requirements, EPCS workflows, and process challenges. They are accompanied by Imprivata’s Chief Medical Officer, Sean Kelly, and Chief Technology Officer, David Ting, who provide insight on the topic from legislative, technical, clinical, and pharmacy workflow perspectives.
Some of the questions they cover include:
- Where can I obtain information regarding New York State’s requirements for EPCS?
- What is the difference between institutional and individual identity proofing, and do I have to be credentialed for multiple systems?
- What authentication modalities are DEA compliant, and which ones may be right for our workflow?
- Who should credential the ID proofing and who can audit our system?
- Can I send an electronic prescription for a controlled substance to an out-of-state pharmacy?